Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63


BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.

Oster C, Wilde B, Specker C, Sun M, Kribben A, Witzke O, Dolff S.

Int J Mol Sci. 2019 Sep 11;20(18). pii: E4505. doi: 10.3390/ijms20184505.


Expression pattern of co-inhibitory molecules on CMV-specific T-cells in lung transplant patients.

Bessa V, Sun M, Meier M, Zeng Y, Xu S, Dolff S, Sommerwerck U, Korth J, Taube C, Aigner C, Kamler M, Kribben A, Lindemann M, Witzke O, Wilde B.

Clin Immunol. 2019 Sep 6;208:108258. doi: 10.1016/j.clim.2019.108258. [Epub ahead of print]


HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.

Rohn H, Michita RT, Schramm S, Dolff S, Gäckler A, Korth J, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V.

Cells. 2019 Aug 7;8(8). pii: E847. doi: 10.3390/cells8080847.


Sex-Specific Differences in HLA Antibodies after Pneumococcal Vaccination in Kidney Transplant Recipients.

Lindemann M, Oesterreich S, Wilde B, Eisenberger U, Muelling N, Horn PA, Heinemann FM, Witzke O.

Vaccines (Basel). 2019 Aug 6;7(3). pii: E84. doi: 10.3390/vaccines7030084.


IL-22 production of effector CD4+ T-cells is altered in SLE patients.

Dolff S, Scharpenberg C, Specker C, Kribben A, Witzke O, Wilde B.

Eur J Med Res. 2019 Jul 22;24(1):24. doi: 10.1186/s40001-019-0385-6.


Th17 cells: do regulatory B-cells (Breg) take control in ANCA-vasculitis?

Dolff S, Witzke O, Wilde B.

Rheumatology (Oxford). 2019 Aug 1;58(8):1329-1330. doi: 10.1093/rheumatology/kez133. No abstract available.


Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants.

Gäckler A, Dolff S, Rohn H, Korth J, Wilde B, Eisenberger U, Mitchell A, Kribben A, Witzke O.

BMC Nephrol. 2019 May 14;20(1):167. doi: 10.1186/s12882-019-1340-z.


B-cell dynamics during experimental endotoxemia in humans.

Brinkhoff A, Zeng Y, Sieberichs A, Dolff S, Shilei X, Sun M, Engler H, Benson S, Korth J, Schedlowski M, Kribben A, Witzke O, Wilde B.

Biosci Rep. 2019 May 17;39(5). pii: BSR20182347. doi: 10.1042/BSR20182347. Print 2019 May 31.


Enhancement of Cytomegalovirus-Specific Cytokine Production after Modulation of the Costimulation in Kidney Transplant Patients.

Dornieden T, Wilde B, Korth J, Werner K, Horn PA, Witzke O, Lindemann M.

J Immunol Res. 2019 Feb 25;2019:3926175. doi: 10.1155/2019/3926175. eCollection 2019.


Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis.

Wilde B, Katsounas A.

Mediators Inflamm. 2019 Feb 25;2019:7537649. doi: 10.1155/2019/7537649. eCollection 2019. Review.


Fate of CD8+: Cytotoxic or Suppressor T Cells in Antibody-mediated Rejection in Solid Organ Transplantation?

Dolff S, Wilde B, Tebbe B.

Transplantation. 2019 Sep;103(9):1756-1757. doi: 10.1097/TP.0000000000002684. No abstract available.


The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.

Korth J, Anastasiou OE, Bräsen JH, Brinkhoff A, Lehmann U, Kribben A, Dittmer U, Verheyen J, Wilde B, Ciesek S, Witzke O, Widera M.

J Clin Virol. 2019 Apr;113:14-19. doi: 10.1016/j.jcv.2019.02.002. Epub 2019 Feb 10.



Wilde BB, Park DJ.

Prim Care. 2019 Mar;46(1):53-68. doi: 10.1016/j.pop.2018.10.007. Epub 2018 Dec 22. Review.


Th17 cells in renal inflammation and autoimmunity.

Dolff S, Witzke O, Wilde B.

Autoimmun Rev. 2019 Feb;18(2):129-136. doi: 10.1016/j.autrev.2018.08.006. Epub 2018 Dec 17. Review.


The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients.

Lindemann M, Korth J, Sun M, Xu S, Struve C, Werner K, Dornieden T, Horn PA, Witzke O, Wilde B.

Int J Mol Sci. 2018 Dec 8;19(12). pii: E3945. doi: 10.3390/ijms19123945.


Are Adverse Events Induced by the Acute Administration of Calcineurin Inhibitor Cyclosporine A Behaviorally Conditioned in Healthy Male Volunteers?

Kahl AL, Kirchhof J, Petrakova L, Müller J, Laubrock J, Brinkhoff A, Unteroberdörster M, Benson S, Wilde B, Witzke O, Schedlowski M.

Clin Ther. 2018 Nov;40(11):1868-1877. doi: 10.1016/j.clinthera.2018.09.008. Epub 2018 Oct 25.


Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.

Korth J, Anastasiou OE, Verheyen J, Dickow J, Sertznig H, Frericks N, Bleekmann B, Kribben A, Brinkhoff A, Wilde B, Sutter K, Dittmer U, Ciesek S, Witzke O, Widera M.

Antiviral Res. 2018 Nov;159:68-76. doi: 10.1016/j.antiviral.2018.09.013. Epub 2018 Sep 27.


T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients.

Gliga S, Korth J, Krawczyk A, Wilde B, Horn PA, Witzke O, Lindemann M, Fiedler M.

J Clin Virol. 2018 Aug;105:91-96. doi: 10.1016/j.jcv.2018.06.009. Epub 2018 Jun 12.


Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected.

Brinkhoff A, Sieberichs A, Engler H, Dolff S, Benson S, Korth J, Schedlowski M, Kribben A, Witzke O, Wilde B.

Front Immunol. 2018 May 18;9:1133. doi: 10.3389/fimmu.2018.01133. eCollection 2018.


The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.

Rohn H, Tomoya Michita R, Schwich E, Dolff S, Gäckler A, Trilling M, Le-Trilling VTK, Wilde B, Korth J, Heinemann FM, Horn PA, Kribben A, Witzke O, Rebmann V.

Front Immunol. 2018 May 8;9:917. doi: 10.3389/fimmu.2018.00917. eCollection 2018.

Supplemental Content

Loading ...
Support Center